Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Revenue (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Revenue for 16 consecutive years, with $173.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 31.95% year-over-year to $173.0 million, compared with a TTM value of $775.4 million through Dec 2025, down 6.07%, and an annual FY2025 reading of $775.4 million, down 3.01% over the prior year.
  • Revenue was $173.0 million for Q4 2025 at Orthofix Medical, down from $229.4 million in the prior quarter.
  • Across five years, Revenue topped out at $254.2 million in Q4 2024 and bottomed at $67.0 million in Q4 2022.
  • Average Revenue over 5 years is $156.7 million, with a median of $171.8 million recorded in 2023.
  • The sharpest move saw Revenue tumbled 39.32% in 2022, then soared 257.94% in 2023.
  • Year by year, Revenue stood at $110.3 million in 2021, then crashed by 39.32% to $67.0 million in 2022, then skyrocketed by 257.94% to $239.6 million in 2023, then rose by 6.07% to $254.2 million in 2024, then plummeted by 31.95% to $173.0 million in 2025.
  • Business Quant data shows Revenue for OFIX at $173.0 million in Q4 2025, $229.4 million in Q3 2025, and $191.4 million in Q2 2025.